GlassScriptPhysician profile
Andrew David Pansick
NPI 1124551163
$7,272.73
in general payments reported to CMS, 2019-2025
18 companies · $4,007 in 2025
The $4,007 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $416 · 2023: $1,105 · 2024: $1,591 · 2025: $4,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,057 · Consulting Fee: $1,500 · Education: $99.99 · Travel and Lodging: $46.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,057.00 |
| Consulting Fee | $1,500.00 |
| Education | $99.99 |
| Travel and Lodging | $46.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $2,226.89 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $1,873.52 | 2021-2025 | Clareon, Clareon Panoptix Pro, Acrysof Iq Vivity |
| Biotissue Holdings INC. | $924.02 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $474.50 | 2023-2025 | Xiidra, Miebo, Ic-8 Apthera Iol |
| Glaukos Corporation | $365.86 | 2021-2023 | Photrexa Cross-Linking Kit |
| Amgen INC. | $310.10 | 2025 | Tepezza |
| Genmab U.S., INC. | $283.74 | 2023-2024 | Tivdak |
| Sun Pharmaceutical Industries INC. | $265.22 | 2023-2025 | Cequa |
| Abbvie INC. | $137.71 | 2023-2025 | |
| Seagen INC. | $99.99 | 2025 | |
| Astellas Pharma US INC | $80.53 | 2023-2024 | Izervay |
| Harrow Eye, LLC | $59.34 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $55.59 | 2022-2023 | |
| Rayner Intraocular Lenses Limited | $38.14 | 2024-2025 | Omidria, Rayone Aspheric, Rayone Emv |
| Dompe US, INC. | $27.73 | 2025 | Oxervate |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $21.24 | 2022 | |
| Rxsight INC | $16.01 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Carl Zeiss Meditec USA, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Pansick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.